Impact of the extent of lymph node dissection on survival outcomes in clinically lymph <scp>node‐positive</scp> bladder cancerMarkus von Deimling, Noor van Ginkel, Mara Bacchiani et al.|British Journal of Urology|2023Cited by 19
Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomyRenate Pichler, Laura S. Mertens, Josef Fritz et al.|The Oncologist|2024Cited by 9
The optimal number of induction chemotherapy cycles in clinically lymph node‐positive bladder cancerMarkus von Deimling, Laura S. Mertens, Marc A. Furrer et al.|British Journal of Urology|2024Cited by 7